New program tackles stigma to get more women with HIV screened for cervical cancer

NCT ID NCT05736588

Completed Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a program called Elimisha HPV, designed to reduce stigma and increase cervical cancer screening among women living with HIV in Kenya. The program included simple educational scripts, a video addressing fears, and peer support. Nearly 1,000 women participated, and researchers measured how many got screened for HPV and followed up for treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Elimisha HPV (behavioral intervention: education, peer navigation, patient-centered delivery)
What this could lead to: If successful, this model could increase cervical cancer screening rates among women living with HIV, reducing cancer risk in a high-stigma population.
What could go wrong: This is a completed behavioral study, not a drug trial. Results may not apply outside Kenya or to other populations. Stigma reduction is complex and hard to scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer HIV infectious disease human papilloma virus infection Social Stigma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HIV HPV STIGMA

Contacts and locations

Locations

Kenya Medical Research Institute

Kisumu, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.